TrialGeriatrics & gerontology international2021

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification study.

Yukari Tsubata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.